Exel Corporation Exel Tb Tuberculin Syringes

Yes, these Exel Tb Tuberculin Syringes feature latex-free construction.

This design is a primary selling point, ensuring compatibility and significantly reducing the risk of allergic reactions for patients and practitioners with latex sensitivities.

Yes, the Exel Tb Tuberculin Syringes are available in configurations that include integrated Safety Needles.

These safety variants are designed to protect practitioners from accidental needlestick injuries while maintaining high clinical standards. Key features of the safety configurations include:

• Zero Dead Space Design: This crucial feature minimizes medication waste, ensuring you deliver the maximum intended dose.
• Capacity: 1cc capacity, often paired with a Luer Lock connection.
• Needle Options: Available in specific sizes, such as 25G x 1” and 23G x 1”.
• Latex-Free: The entire line of syringes is constructed without latex, promoting patient and staff safety regarding allergic reactions.

These Exel Tb Tuberculin Syringes are designed for highly accurate, small-volume fluid administration. They utilize specialized P.A. needles and incorporate a Zero Dead Space design to minimize medication waste and ensure maximum dose delivery.

The following precise needle gauge and length options are available:

• 25G x 5/8”: Commonly offered in fixed needle/syringe combinations.
• 25G x 1”: Available in 1cc capacity, often featuring Luer Lock connections and safety needle options.
• 23G x 1”: Also offered in 1cc Luer Lock and safety needle configurations.

Yes, the Exel Tb Tuberculin Syringes are designed with Zero Dead Space technology. This is a crucial feature for precision and efficiency in medical administration, ensuring patients receive the maximum intended dose.

• Minimized Medication Waste: The design significantly reduces the residual volume left in the syringe barrel and needle hub after injection.
• Enhanced Accuracy: By minimizing dead space, the syringe ensures highly accurate dosage delivery, which is especially vital for small-volume injections like tuberculin testing.

The Exel Tb Tuberculin Syringes are sold in bulk quantities suitable for clinical environments, but the specific packaging format depends on the syringe configuration chosen.

Here are the primary bulk packaging options:

• For Fixed Needle/Zero Dead Space Syringes (e.g., 25G x 5/8”):
  • 10 syringes per bag (bg)
  • 10 bags per box (bx)
  • 5 boxes per case (cs)
• For Luer Lock Syringes with Safety Needles (e.g., 25x1” or 23x1”):
  • 50 syringes per box (bx)
  • 6 boxes per case (cs)

These Exel Tb Tuberculin Syringes are specifically designed for procedures requiring highly accurate, small-volume injections where dosage precision is paramount.

They are ideal for:

• Tuberculin Skin Testing (TST) or PPD injections, as indicated by the ‘Tb’ designation.
• Other intradermal or subcutaneous injections requiring precise, critical dosing.

A major benefit supporting this precision is the Zero Dead Space design, which minimizes medication waste by ensuring virtually no residual volume remains in the syringe after injection. Furthermore, the syringes feature latex-free construction for enhanced patient safety.

Yes, the Zero Dead Space design is a key feature specifically engineered to maximize medication delivery and precision.

This technology provides significant benefits, especially for small-volume injections such as tuberculin testing:

• Minimizes Medication Waste: The design drastically reduces the residual volume of medication left in the syringe barrel and needle hub after the plunger is fully depressed.
• Ensures Accurate Dosing: By virtually eliminating ‘dead space,’ the patient receives the most complete and precise intended dose, which is critical for highly accurate administration.

Yes, these Exel Tb Tuberculin Syringes are designed strictly for single-use. As sterile, individually packaged medical devices, they must be disposed of after one use to prevent the risk of cross-contamination and ensure patient safety during procedures like TST and small-volume injections.